Cargando…

Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

BACKGROUND: Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and benzodiazepine anxiolytics are used in the US to treat generalized anxiety disorder (GAD). While benzodiazepines typically provide rapid symptomatic relief, long-term use is not recommended due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Ariel, Edelsberg, John, Treglia, Michael, Alvir, Jose Ma J, Oster, Gerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504522/ https://www.ncbi.nlm.nih.gov/pubmed/23088742 http://dx.doi.org/10.1186/1471-244X-12-177

Ejemplares similares

Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2011)

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder
por: Berger, Ariel, et al.
Publicado: (2009)

Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
por: Berger, Ariel, et al.
Publicado: (2014)

Characteristics and healthcare costs of patients with fibromyalgia syndrome
por: Berger, A, et al.
Publicado: (2007)

Resource utilization and costs before and after total joint arthroplasty
por: Bozic, Kevin J, et al.
Publicado: (2012)

Benzodiazepine-Receptor Agonist Utilization in Outpatients with Anxiety Disorder: A Retrospective Study Based on Electronic Healthcare Data from a Large General Tertiary Hospital
por: Liu, Denong, et al.
Publicado: (2023)

Benzodiazepine Usage, Healthcare Resource Utilization, and Costs Among Older Adults Treated with Common Insomnia Medications: A Retrospective Cohort Study
por: Wickwire, Emerson M, et al.
Publicado: (2023)

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
por: Vera-Llonch, Montserrat, et al.
Publicado: (2009)

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
por: Reynolds, Shannon L., et al.
Publicado: (2017)

Benzodiazepines prescribing in anxiety : Between practice and guidelines
por: Lagha, M., et al.
Publicado: (2021)

Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines
por: Amari, Diana T., et al.
Publicado: (2022)

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety
por: Engel, Odilo, et al.
Publicado: (2018)

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
por: De Salas-Cansado, Marina, et al.
Publicado: (2012)

Reduction in the use of benzodiazepines and cyclopyrrolones in general practice
por: Jørgensen, Viggo K., et al.
Publicado: (2008)

Shared structural mechanisms of general anesthetics and benzodiazepines
por: Kim, Jeong Joo, et al.
Publicado: (2020)

Tunisian general practitioner’s perception of benzodiazepine prescription:
por: Boudriga, S., et al.
Publicado: (2023)

Benzodiazepine Prescription for Anxiety Disorders Increase the Risk of Substance Use Disorders: A Retrospective Cohort Study
por: Sun, C.-F., et al.
Publicado: (2023)

Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures
por: Weycker, D., et al.
Publicado: (2017)

Patterns of benzodiazepines use in primary care adults with anxiety disorders
por: Tanguay Bernard, Marie-Michèle, et al.
Publicado: (2018)

Benzodiazepines Withdrawal: Initial Outcomes and Long-Term Impact on Falls in a French Nursing Home
por: Javelot, Hervé, et al.
Publicado: (2018)

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Trends in US Hospital Admissions for Skin and Soft Tissue Infections
por: Edelsberg, John, et al.
Publicado: (2009)

Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders
por: Chapoutot, Mélinée, et al.
Publicado: (2021)

Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
por: Oster, Gerry, et al.
Publicado: (2022)

Healthcare utilization and costs associated with gastroparesis
por: Wadhwa, Vaibhav, et al.
Publicado: (2017)

Healthcare utilization and costs associated with cholangiocarcinoma
por: Wadhwa, Vaibhav, et al.
Publicado: (2017)

Baclofen in the short-term maintenance treatment of benzodiazepine dependence
por: Shukla, Lekhansh, et al.
Publicado: (2014)

Is Long-term Use of Benzodiazepine a Risk for Cancer?
por: Iqbal, Usman, et al.
Publicado: (2015)

Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
por: Garel, Nicolas, et al.
Publicado: (2023)

A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
por: Silva Miguel, Luís, et al.
Publicado: (2013)

Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review
por: Wright, Steven L.
Publicado: (2020)

Assessing the clinical utility of the severity dependence scale for benzodiazepine use disorder
por: Lowton, Karishma, et al.
Publicado: (2021)

Benzodiazepines utilization in Brazilian older adults: a population-based study
por: Freire, Marina de Borba Oliveira, et al.
Publicado: (2022)

Association of opioid use disorder with healthcare utilization and cost in a public health system
por: Miron, Oren, et al.
Publicado: (2022)

Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative
por: Carr, Frances, et al.
Publicado: (2019)

Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study
por: Nakajima, Aiichiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lk4e7hnq0m3hqfd00navnn00e5